Rare disease genes found in some people diagnosed with MS

Credibility

Interest

Share:2 min read

Key Takeaway

Some people diagnosed with MS carried rare gene changes linked to diseases that can look like MS.

What They Found

Researchers studied gene data from people diagnosed with MS, inflammatory bowel disease, or atopic dermatitis. Among people diagnosed with MS in the U.K. Biobank, 53 of 1,850 carried a rare gene change linked to another disease. Rare gene changes were also found in 75 of 6,681 people diagnosed with inflammatory bowel disease. They were found in 25 of 998 people diagnosed with atopic dermatitis. Researchers found similar results in separate groups with MS or inflammatory bowel disease, but the abstract gives no counts for those groups.

Who Should Care and Why

The study included people diagnosed with MS, inflammatory bowel disease, or atopic dermatitis. It may matter to people diagnosed with MS because some rare diseases can cause similar symptoms. The researchers looked for gene changes linked to those rare diseases. They also studied whether gene tests might help explain why a treatment did not work well for someone. The study raises questions about diagnosis; it does not show that everyone with a gene change was misdiagnosed.

Important Considerations

You should know this was an analysis of gene data, not a test of a treatment. The U.K. Biobank analysis included 9,529 people across three diagnosed conditions. The abstract does not say how many people were in the separate groups or confirm that those with rare gene changes had incorrect diagnoses.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics MS Genetics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like The New England journal of medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News